RAASi Enabling in the Modern Era

Slides:



Advertisements
Similar presentations
Prior Trials of RAAS Inhibitors
Advertisements

Current State of Hyperkalemia Management
Introduction: Alarming Statistics Causes of Death in Prevalent Dialysis Patients,
Advancing Management of Anemia With the Latest Data From ERA-EDTA 2018
Making the Case for Metabolic Surgery in Patients With Obesity and T2DM.
CV Risk Management in Diabetes: A Mandate for GLP-1 Receptor Agonists?
PCP Perspectives Pathophysiologic Principles in the Management of Hyperkalemia.
Diabetes and Dyslipidemia
Cardiogenic Shock.
Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.
Heart Rate, HF Admissions, and Readmissions
New Therapies for Hyperkalemia Across the Continuum of Care
A CASE CHALLENGE IN HFrEF:
At The Cutting Edge of Developments in the Management of Hyperkalemia
Updates Abound in Hyperkalemia Management
Patient Case Discussions in T2D: What Intensification Plan Is Best?
The Latest Data on Oral Prostacyclin Therapy in PAH
PCP Perspectives Clinical Considerations in Hyperkalemia
SGLT2 Inhibitors in the Modern Era: Why and Where?
Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.
Strategies to Improve Adherence and Persistence in the Treatment of Hypertension.
Program Goals. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?
Blood pressure control: dependence on adherence
Tailoring Hemophilia Prophylaxis Therapy
When Would You Use Single Inhaler Triple Therapy in COPD?
Treating HFrEF: Challenges Faced
Should SGLT2 Inhibitors Be the Primary Agents for CV Risk Reduction in T2DM?
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
Expert Perspectives on Hyperkalemia for the Specialist
Evaluating LDL-C Recommendations
The future of urate-lowering strategies for gout
Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.
Exploring Emerging Treatments for Hyperkalemia
Tackling CV Risk in T2DM.
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
At The Cutting Edge of Developments in the Management of Hyperkalemia
New LDL-C Lipid Targets
Panelists. Secondary Prevention in Patients With ACS and Diabetes: How Can We Optimize Therapy?
Multidisciplinary Management of Hyperkalemia:
Lipid Clinic Challenge
Hyperkalemia in the Hospital
Updates in Heart Failure:
When to Start and What to Use
The Road to Quality Improvement in HER2-Positive Breast Cancer
T2DM, CV Risk, and Modulating Risk With Glucose-Lowering Strategies
Diabetes Pandemic. The Economics of Managing Patients With Diabetes and Coronary Artery Disease: A Payer Perspective.
Oral Prostacyclin Pathway Agents in PAH
Liraglutide Shows CV Benefit: Clinical Perspectives on the LEADER Trial
Glucose Management and Statin Therapy
Controlling Elevated Blood Pressure
The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.
Potential mechanisms whereby statins may reduce the risk of stroke
Maximizing Organ Protection in Patients With CKD and Comorbidities on RAAS Therapy.
Improving Adherence to Antiplatelet Therapy After an ACS Event
Assessing the Burden of Hyperkalemia
Breaking Down the Data in Hyperkalemia
Transitioning Therapy in PAH: Practical Strategies and Considerations
Assessing the Burden of Hyperkalemia
Glucose Management and Statin Therapy
Should SGLT2 Inhibitors Be the Primary Agents for CV Risk Reduction in T2DM?
Early Treatment of Diabetic Retinopathy
What's New in Oral Combination Therapy for Type 2 Diabetes?
Clinical Comparisons.
Risk Stratification of Patients With Type 2 Diabetes: An Interpretation of the Latest Treatment Guidelines.
Targeted Care for COPD.
An updated general approach for achieving BP goals in people with diabetes. An updated general approach for achieving BP goals in people with diabetes.
Case Study #1. Management of Heart Failure With Comorbidities: Challenging Cases for the Cardiologist.
Case-Based Look at Hyperkalemia Identification, Diagnosis, and Management.
Potassium Situations Resolved
Presentation transcript:

RAASi Enabling in the Modern Era

Risk-Benefit of RAASi Use

RENAAL Trial

High-Potassium--Containing Foods

Treatment Options for Hyperkalemia

Potassium Binders

Guideline Recommendations Regarding RAASi Use Based on Serum Potassium Level

RENAAL Study Post-Hoc Analysis Cardiorenal Benefit

Potassium Binding Therapy Patiromer

Effect of Lower Potassium on BP Control in Diabetic Nephropathy

Meta-Analysis of ACEi-Associated Elevations in sCr

ACCORD-BP Post-Hoc Analysis Creatinine Rise and BP-Lowering Treatment

Potential Long-Term Strategy to Maintain Normokalemia and Enable RAASi Therapy

DIAMOND Trial Management of Hyperkalemia in Patients With HF

Providing Patient Education for Hyperkalemia

Abbreviations

Abbreviations (cont)

Abbreviations (cont)